| Stephen Beyers, LPC | |
|
9192 S 300 W, #19, Sandy, UT 84070-2671 | |
| (801) 554-3191 | |
| (801) 523-9239 |
| Full Name | Stephen Beyers |
|---|---|
| Gender | Male |
| Speciality | Counselor - Mental Health |
| Location | 9192 S 300 W, Sandy, Utah |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043552292 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YM0800X | Counselor - Mental Health | 5831651-6004 (Utah) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Stephen Beyers, LPC 456 E Brewster Dr, Draper, UT 84020-5151 Ph: (801) 554-3191 | Stephen Beyers, LPC 9192 S 300 W, #19, Sandy, UT 84070-2671 Ph: (801) 554-3191 |
News Archive
Boston Scientific Corporation has completed patient enrollment in the ASTI post-market clinical follow-up study designed to evaluate its Adapt Monorail Carotid Stent System in combination with its FilterWire EZ Embolic Protection System for treatment of carotid artery disease in patients at high risk for carotid surgery.
DiagnoCure, Inc., a life sciences company commercializing high-value cancer diagnostic tests and delivering laboratory services, announced that its proprietary prostate cancer biomarker PCA3 was the topic of over 13 presentations at the 2010 European Association of Urology meeting, the world largest urology event, held in Barcelona, Spain, with 14,000 registrants.
New data have been presented for the first time at the European Association of Dermato Oncology (EADO) Congress today on the investigational MEK inhibitor cobimetinib (GDC-0973) in combination with BRAFV600 inhibitor Zelboraf® (vemurafenib) for metastatic melanoma, the most aggressive form of skin cancer. The findings illustrate that cobimetinib and vemurafenib can be safely co-administered and that the combination shows promising anti-tumour activity, with a median progression-free survival (mPFS) of 13.7 months for BRAF inhibitor-naive patients.1
Inter Press Service examines the challenges that non-governmental organizations and the government face in trying to prevent fistula among women in the Democratic Republic of Congo, where an estimated 12,000 cases are recorded annually because of sexual violence, early marriage and complications in childbirth, according to the Ministry of Public Health. Poverty, early pregnancy and marriage, sexual violence, and a lack of education and knowledge about the condition contribute to its prevalence, IPS reports.
In a new study published in American Journal of Human Genetics, a team of researchers led by Charis Eng, M.D., Ph.D., Chair of Cleveland Clinic's Genomic Medicine Institute, identified a metabolite that may predict whether individuals with PTEN mutations will develop cancer or autism spectrum disorder.
› Verified 7 days ago
Jacqueline Hyde, Counselor Medicare: Not Enrolled in Medicare Practice Location: 10151 Majestic Canyon Rd, Sandy, UT 84092 Phone: 801-809-5050 | |
Jason Vaughn Shoemaker, PHD Counselor Medicare: Not Enrolled in Medicare Practice Location: 9045 S 1300 E, Sandy, UT 84094 Phone: 801-666-6834 | |
Mrs. Sandra Lee Chew, MS, CMHC, NCC Counselor Medicare: Not Enrolled in Medicare Practice Location: 1270 E 8600 S Ste 3, Sandy, UT 84094 Phone: 801-676-9160 Fax: 801-606-2766 | |
David S Bridgeman, LMFT Counselor Medicare: Not Enrolled in Medicare Practice Location: 781 E Autumn Field Dr, Sandy, UT 84094 Phone: 801-633-3928 | |
Mrs. Bonita Gray Kolb, L.P.C. Counselor Medicare: Not Enrolled in Medicare Practice Location: 8160 Highland Dr, Building A, Sandy, UT 84093 Phone: 801-831-4339 | |
Wendy Meyer, CMHC, NCC Counselor Medicare: Not Enrolled in Medicare Practice Location: 9361 S 300 E, Sandy, UT 84070 Phone: 801-826-5000 |